KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 144 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $325,000 | +66.7% | 59,480 | +124.6% | 0.00% | 0.0% |
| Q1 2022 | $195,000 | +5.4% | 26,482 | -8.0% | 0.00% | – |
| Q4 2021 | $185,000 | +12.1% | 28,798 | +1.4% | 0.00% | – |
| Q3 2021 | $165,000 | -43.5% | 28,400 | +0.4% | 0.00% | -100.0% |
| Q2 2021 | $292,000 | +5.8% | 28,300 | +49.7% | 0.00% | -50.0% |
| Q3 2020 | $276,000 | -70.1% | 18,900 | -60.6% | 0.00% | -71.4% |
| Q1 2020 | $922,000 | -8.6% | 48,000 | -8.8% | 0.01% | 0.0% |
| Q4 2019 | $1,009,000 | – | 52,616 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |